JP2010518942A - 不安定プラークまたは動脈瘤のような脆弱化した血管壁の治療 - Google Patents
不安定プラークまたは動脈瘤のような脆弱化した血管壁の治療 Download PDFInfo
- Publication number
- JP2010518942A JP2010518942A JP2009550369A JP2009550369A JP2010518942A JP 2010518942 A JP2010518942 A JP 2010518942A JP 2009550369 A JP2009550369 A JP 2009550369A JP 2009550369 A JP2009550369 A JP 2009550369A JP 2010518942 A JP2010518942 A JP 2010518942A
- Authority
- JP
- Japan
- Prior art keywords
- heating
- ultrasonic
- ultrasound
- blood vessel
- plaque
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 206010002329 Aneurysm Diseases 0.000 title claims description 55
- 238000010438 heat treatment Methods 0.000 claims abstract description 99
- 238000000034 method Methods 0.000 claims abstract description 73
- 230000005856 abnormality Effects 0.000 claims abstract description 33
- 230000008859 change Effects 0.000 claims abstract description 26
- 230000002792 vascular Effects 0.000 claims abstract description 15
- 230000000087 stabilizing effect Effects 0.000 claims abstract description 10
- 210000004204 blood vessel Anatomy 0.000 claims description 90
- 238000002604 ultrasonography Methods 0.000 claims description 88
- 102000008186 Collagen Human genes 0.000 claims description 35
- 108010035532 Collagen Proteins 0.000 claims description 35
- 229920001436 collagen Polymers 0.000 claims description 35
- 238000012544 monitoring process Methods 0.000 claims description 35
- 238000004132 cross linking Methods 0.000 claims description 26
- 230000006641 stabilisation Effects 0.000 claims description 20
- 238000011105 stabilization Methods 0.000 claims description 20
- 238000001514 detection method Methods 0.000 claims description 18
- 150000002632 lipids Chemical class 0.000 claims description 11
- 210000001367 artery Anatomy 0.000 claims description 7
- 239000002775 capsule Substances 0.000 claims description 7
- 230000006496 vascular abnormality Effects 0.000 claims description 7
- 230000002159 abnormal effect Effects 0.000 claims description 6
- 238000002091 elastography Methods 0.000 claims description 6
- 230000005855 radiation Effects 0.000 claims description 6
- 238000002595 magnetic resonance imaging Methods 0.000 claims description 5
- 230000001112 coagulating effect Effects 0.000 claims description 4
- 238000002113 ultrasound elastography Methods 0.000 claims description 4
- 206010060965 Arterial stenosis Diseases 0.000 claims description 3
- 210000001519 tissue Anatomy 0.000 description 61
- 230000008602 contraction Effects 0.000 description 10
- 238000010521 absorption reaction Methods 0.000 description 9
- 239000011248 coating agent Substances 0.000 description 9
- 238000000576 coating method Methods 0.000 description 9
- 239000000523 sample Substances 0.000 description 9
- 238000003384 imaging method Methods 0.000 description 8
- 238000000527 sonication Methods 0.000 description 8
- 230000017531 blood circulation Effects 0.000 description 7
- 208000007536 Thrombosis Diseases 0.000 description 6
- 210000000709 aorta Anatomy 0.000 description 6
- 238000002608 intravascular ultrasound Methods 0.000 description 6
- 239000012528 membrane Substances 0.000 description 6
- 238000012014 optical coherence tomography Methods 0.000 description 6
- 238000002591 computed tomography Methods 0.000 description 5
- 210000004177 elastic tissue Anatomy 0.000 description 5
- 230000003902 lesion Effects 0.000 description 5
- 238000001356 surgical procedure Methods 0.000 description 5
- 208000007474 aortic aneurysm Diseases 0.000 description 4
- 238000010586 diagram Methods 0.000 description 4
- 239000000835 fiber Substances 0.000 description 4
- 230000008569 process Effects 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- 108090000623 proteins and genes Proteins 0.000 description 4
- 230000004044 response Effects 0.000 description 4
- 230000001225 therapeutic effect Effects 0.000 description 4
- 230000019552 anatomical structure morphogenesis Effects 0.000 description 3
- 230000007850 degeneration Effects 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 238000013021 overheating Methods 0.000 description 3
- 230000009467 reduction Effects 0.000 description 3
- 238000010183 spectrum analysis Methods 0.000 description 3
- 230000008685 targeting Effects 0.000 description 3
- 230000003685 thermal hair damage Effects 0.000 description 3
- 208000037260 Atherosclerotic Plaque Diseases 0.000 description 2
- 102000016942 Elastin Human genes 0.000 description 2
- 108010014258 Elastin Proteins 0.000 description 2
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 2
- WZUVPPKBWHMQCE-UHFFFAOYSA-N Haematoxylin Chemical compound C12=CC(O)=C(O)C=C2CC2(O)C1C1=CC=C(O)C(O)=C1OC2 WZUVPPKBWHMQCE-UHFFFAOYSA-N 0.000 description 2
- 208000032843 Hemorrhage Diseases 0.000 description 2
- 208000002223 abdominal aortic aneurysm Diseases 0.000 description 2
- 238000013459 approach Methods 0.000 description 2
- 208000034158 bleeding Diseases 0.000 description 2
- 231100000319 bleeding Toxicity 0.000 description 2
- 230000000740 bleeding effect Effects 0.000 description 2
- 238000001311 chemical methods and process Methods 0.000 description 2
- 230000004087 circulation Effects 0.000 description 2
- 230000015271 coagulation Effects 0.000 description 2
- 238000005345 coagulation Methods 0.000 description 2
- 210000002808 connective tissue Anatomy 0.000 description 2
- 210000004351 coronary vessel Anatomy 0.000 description 2
- 230000034994 death Effects 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 229920002549 elastin Polymers 0.000 description 2
- 238000004880 explosion Methods 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 230000002093 peripheral effect Effects 0.000 description 2
- 238000001126 phototherapy Methods 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 238000009210 therapy by ultrasound Methods 0.000 description 2
- 230000002885 thrombogenetic effect Effects 0.000 description 2
- 230000002477 vacuolizing effect Effects 0.000 description 2
- 208000031104 Arterial Occlusive disease Diseases 0.000 description 1
- 206010053567 Coagulopathies Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 201000008450 Intracranial aneurysm Diseases 0.000 description 1
- 102000007330 LDL Lipoproteins Human genes 0.000 description 1
- 108010007622 LDL Lipoproteins Proteins 0.000 description 1
- 208000031481 Pathologic Constriction Diseases 0.000 description 1
- 241000282898 Sus scrofa Species 0.000 description 1
- 201000008982 Thoracic Aortic Aneurysm Diseases 0.000 description 1
- 206010053648 Vascular occlusion Diseases 0.000 description 1
- 206010047163 Vasospasm Diseases 0.000 description 1
- 230000033115 angiogenesis Effects 0.000 description 1
- 230000002491 angiogenic effect Effects 0.000 description 1
- 208000021328 arterial occlusion Diseases 0.000 description 1
- 230000003143 atherosclerotic effect Effects 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000031018 biological processes and functions Effects 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 230000035602 clotting Effects 0.000 description 1
- 238000004891 communication Methods 0.000 description 1
- 230000021615 conjugation Effects 0.000 description 1
- 238000011461 current therapy Methods 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- YQGOJNYOYNNSMM-UHFFFAOYSA-N eosin Chemical compound [Na+].OC(=O)C1=CC=CC=C1C1=C2C=C(Br)C(=O)C(Br)=C2OC2=C(Br)C(O)=C(Br)C=C21 YQGOJNYOYNNSMM-UHFFFAOYSA-N 0.000 description 1
- 210000003238 esophagus Anatomy 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 230000003631 expected effect Effects 0.000 description 1
- 208000003457 familial thoracic 1 aortic aneurysm Diseases 0.000 description 1
- 239000003527 fibrinolytic agent Substances 0.000 description 1
- 230000003176 fibrotic effect Effects 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 230000001678 irradiating effect Effects 0.000 description 1
- 210000005228 liver tissue Anatomy 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- 210000004088 microvessel Anatomy 0.000 description 1
- 230000003562 morphometric effect Effects 0.000 description 1
- 238000013425 morphometry Methods 0.000 description 1
- 230000002107 myocardial effect Effects 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- 230000001338 necrotic effect Effects 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 230000000750 progressive effect Effects 0.000 description 1
- 210000004777 protein coat Anatomy 0.000 description 1
- 238000004445 quantitative analysis Methods 0.000 description 1
- 238000012958 reprocessing Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000012502 risk assessment Methods 0.000 description 1
- 238000004904 shortening Methods 0.000 description 1
- 230000036262 stenosis Effects 0.000 description 1
- 208000037804 stenosis Diseases 0.000 description 1
- 230000008719 thickening Effects 0.000 description 1
- 239000010409 thin film Substances 0.000 description 1
- 229960000103 thrombolytic agent Drugs 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- 230000001228 trophic effect Effects 0.000 description 1
- 208000021331 vascular occlusion disease Diseases 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N7/00—Ultrasound therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/18—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/0048—Detecting, measuring or recording by applying mechanical forces or stimuli
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B8/00—Diagnosis using ultrasonic, sonic or infrasonic waves
- A61B8/48—Diagnostic techniques
- A61B8/485—Diagnostic techniques involving measuring strain or elastic properties
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N7/00—Ultrasound therapy
- A61N7/02—Localised ultrasound hyperthermia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B2017/00017—Electrical control of surgical instruments
- A61B2017/00022—Sensing or detecting at the treatment site
- A61B2017/00106—Sensing or detecting at the treatment site ultrasonic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B17/22—Implements for squeezing-off ulcers or the like on inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; for invasive removal or destruction of calculus using mechanical vibrations; for removing obstructions in blood vessels, not otherwise provided for
- A61B2017/22001—Angioplasty, e.g. PCTA
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B17/22—Implements for squeezing-off ulcers or the like on inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; for invasive removal or destruction of calculus using mechanical vibrations; for removing obstructions in blood vessels, not otherwise provided for
- A61B2017/22081—Treatment of vulnerable plaque
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N7/00—Ultrasound therapy
- A61N2007/0078—Ultrasound therapy with multiple treatment transducers
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Animal Behavior & Ethology (AREA)
- Surgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medical Informatics (AREA)
- Molecular Biology (AREA)
- Physics & Mathematics (AREA)
- Heart & Thoracic Surgery (AREA)
- Radiology & Medical Imaging (AREA)
- Pathology (AREA)
- Biophysics (AREA)
- Otolaryngology (AREA)
- Electromagnetism (AREA)
- Plasma & Fusion (AREA)
- Surgical Instruments (AREA)
- Ultra Sonic Daignosis Equipment (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US90249507P | 2007-02-22 | 2007-02-22 | |
| PCT/IL2008/000234 WO2008102363A2 (en) | 2007-02-22 | 2008-02-21 | Treating weakened vessel wall such as vulnerable plaque or aneurysms |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2010518942A true JP2010518942A (ja) | 2010-06-03 |
| JP2010518942A5 JP2010518942A5 (enExample) | 2011-04-07 |
Family
ID=39710601
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009550369A Pending JP2010518942A (ja) | 2007-02-22 | 2008-02-21 | 不安定プラークまたは動脈瘤のような脆弱化した血管壁の治療 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US10463886B2 (enExample) |
| EP (2) | EP2112911B1 (enExample) |
| JP (1) | JP2010518942A (enExample) |
| KR (1) | KR20090121292A (enExample) |
| WO (1) | WO2008102363A2 (enExample) |
Families Citing this family (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8241274B2 (en) | 2000-01-19 | 2012-08-14 | Medtronic, Inc. | Method for guiding a medical device |
| US8150519B2 (en) | 2002-04-08 | 2012-04-03 | Ardian, Inc. | Methods and apparatus for bilateral renal neuromodulation |
| US7756583B2 (en) | 2002-04-08 | 2010-07-13 | Ardian, Inc. | Methods and apparatus for intravascularly-induced neuromodulation |
| US8347891B2 (en) | 2002-04-08 | 2013-01-08 | Medtronic Ardian Luxembourg S.A.R.L. | Methods and apparatus for performing a non-continuous circumferential treatment of a body lumen |
| ES2564694T3 (es) | 2003-09-12 | 2016-03-28 | Vessix Vascular, Inc. | Sistema de remodelación y / o ablación excéntrica seleccionable de material ateroesclerótico |
| US8396548B2 (en) | 2008-11-14 | 2013-03-12 | Vessix Vascular, Inc. | Selective drug delivery in a lumen |
| WO2007140331A2 (en) | 2006-05-25 | 2007-12-06 | Medtronic, Inc. | Methods of using high intensity focused ultrasound to form an ablated tissue area containing a plurality of lesions |
| EP2076193A4 (en) | 2006-10-18 | 2010-02-03 | Minnow Medical Inc | MATCHED RF-ENERGY AND ELECTRO-TISSUE CHARACTERIZATION FOR THE SELECTIVE TREATMENT OF TARGET TISSUE |
| ES2560006T3 (es) | 2006-10-18 | 2016-02-17 | Vessix Vascular, Inc. | Inducción de efectos de temperatura deseables sobre tejido corporal |
| WO2008049087A2 (en) | 2006-10-18 | 2008-04-24 | Minnow Medical, Inc. | System for inducing desirable temperature effects on body tissue |
| US10463886B2 (en) | 2007-02-22 | 2019-11-05 | Ramot At Tel-Aviv University Ltd. | Treating weakened vessel wall such as vulnerable plaque or aneurysms |
| US8496653B2 (en) | 2007-04-23 | 2013-07-30 | Boston Scientific Scimed, Inc. | Thrombus removal |
| KR20110104504A (ko) | 2008-11-17 | 2011-09-22 | 미노우 메디컬, 인코포레이티드 | 조직 토폴로지의 지식 여하에 따른 에너지의 선택적 축적 |
| WO2010080905A2 (en) * | 2009-01-08 | 2010-07-15 | The Board Of Regents Of The University Of Texas System | Real-time in vivo radiation dosimetry using scintillation detectors |
| US8551096B2 (en) | 2009-05-13 | 2013-10-08 | Boston Scientific Scimed, Inc. | Directional delivery of energy and bioactives |
| CN103068330B (zh) | 2010-04-09 | 2016-06-29 | Vessix血管股份有限公司 | 用于治疗组织的功率发生和控制装置 |
| US20120065506A1 (en) * | 2010-09-10 | 2012-03-15 | Scott Smith | Mechanical, Electromechanical, and/or Elastographic Assessment for Renal Nerve Ablation |
| US9028417B2 (en) | 2010-10-18 | 2015-05-12 | CardioSonic Ltd. | Ultrasound emission element |
| WO2012052920A1 (en) * | 2010-10-18 | 2012-04-26 | CardioSonic Ltd. | Therapeutics reservoir |
| US8585601B2 (en) | 2010-10-18 | 2013-11-19 | CardioSonic Ltd. | Ultrasound transducer |
| US9566456B2 (en) | 2010-10-18 | 2017-02-14 | CardioSonic Ltd. | Ultrasound transceiver and cooling thereof |
| EP2694150A1 (en) | 2011-04-08 | 2014-02-12 | Covidien LP | Iontophoresis drug delivery system and method for denervation of the renal sympathetic nerve and iontophoretic drug delivery |
| US10357304B2 (en) * | 2012-04-18 | 2019-07-23 | CardioSonic Ltd. | Tissue treatment |
| US11357447B2 (en) | 2012-05-31 | 2022-06-14 | Sonivie Ltd. | Method and/or apparatus for measuring renal denervation effectiveness |
| US9592027B2 (en) * | 2013-03-14 | 2017-03-14 | Volcano Corporation | System and method of adventitial tissue characterization |
| WO2014145146A1 (en) | 2013-03-15 | 2014-09-18 | Medtronic Ardian Luxembourg S.A.R.L. | Controlled neuromodulation systems and methods of use |
| WO2014188430A2 (en) | 2013-05-23 | 2014-11-27 | CardioSonic Ltd. | Devices and methods for renal denervation and assessment thereof |
| US10709490B2 (en) | 2014-05-07 | 2020-07-14 | Medtronic Ardian Luxembourg S.A.R.L. | Catheter assemblies comprising a direct heating element for renal neuromodulation and associated systems and methods |
| US10779964B2 (en) * | 2015-03-15 | 2020-09-22 | Board Of Trustees Of The Leland Stanford Junior University | Methods, devices, and compositions for treating abdominal aortic aneurysms |
| EP3600434A4 (en) | 2017-03-20 | 2021-01-06 | Sonievie Ltd. | Pulmonary hypertension treatment |
| US12178643B2 (en) | 2017-08-15 | 2024-12-31 | Philips Image Guided Therapy Corporation | Intracardiac therapeutic and diagnostic ultrasound device |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6475210B1 (en) * | 2000-02-11 | 2002-11-05 | Medventure Technology Corp | Light treatment of vulnerable atherosclerosis plaque |
| JP2004503277A (ja) * | 2000-03-08 | 2004-02-05 | ファーマソニックス，インコーポレイテッド | プラーク安定化のための方法、システムおよびキット |
| WO2005030295A2 (en) * | 2003-09-24 | 2005-04-07 | Therus Corporation | Insertable ultrasound probes, systems, and methods for thermal therapy |
| WO2005076729A2 (en) * | 2004-02-12 | 2005-08-25 | Neurosonix Ltd. | Acoustic control of emboli in vivo |
| US20060058711A1 (en) * | 2000-07-13 | 2006-03-16 | Prorhythm, Inc. | Energy application with inflatable annular lens |
Family Cites Families (53)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4867962A (en) | 1988-02-26 | 1989-09-19 | Neorx Corporation | Functionally specific antibodies |
| US5053006A (en) | 1988-04-19 | 1991-10-01 | Watson Brant D | Method for the permanent occlusion of arteries |
| US6537306B1 (en) | 1992-11-13 | 2003-03-25 | The Regents Of The University Of California | Method of manufacture of a transurethral ultrasound applicator for prostate gland thermal therapy |
| US6203775B1 (en) | 1993-03-19 | 2001-03-20 | The General Hospital Corporation | Chelating polymers for labeling of proteins |
| US5405322A (en) | 1993-08-12 | 1995-04-11 | Boston Scientific Corporation | Method for treating aneurysms with a thermal source |
| US5585637A (en) | 1995-06-09 | 1996-12-17 | Adac Laboratories | Multi-head nuclear medicine camera for dual SPECT and PET imaging |
| AU712539B2 (en) * | 1996-01-08 | 1999-11-11 | Biosense, Inc. | Methods and apparatus for myocardial revascularization |
| US5921954A (en) * | 1996-07-10 | 1999-07-13 | Mohr, Jr.; Lawrence G. | Treating aneurysms by applying hardening/softening agents to hardenable/softenable substances |
| IL127017A (en) | 1996-05-17 | 2003-07-06 | Biosense Inc | Self-aligning catheter |
| US7052493B2 (en) * | 1996-10-22 | 2006-05-30 | Epicor Medical, Inc. | Methods and devices for ablation |
| US5827268A (en) * | 1996-10-30 | 1998-10-27 | Hearten Medical, Inc. | Device for the treatment of patent ductus arteriosus and method of using the device |
| US6071303A (en) | 1996-12-08 | 2000-06-06 | Hearten Medical, Inc. | Device for the treatment of infarcted tissue and method of treating infarcted tissue |
| US5906580A (en) | 1997-05-05 | 1999-05-25 | Creare Inc. | Ultrasound system and method of administering ultrasound including a plurality of multi-layer transducer elements |
| EP0989822A4 (en) | 1997-06-23 | 2004-07-28 | Focus Surgery Inc | ACOUSTIC HEMOSTASIS METHODS AND DEVICES |
| US6514249B1 (en) | 1997-07-08 | 2003-02-04 | Atrionix, Inc. | Positioning system and method for orienting an ablation element within a pulmonary vein ostium |
| US6117101A (en) | 1997-07-08 | 2000-09-12 | The Regents Of The University Of California | Circumferential ablation device assembly |
| JP3636579B2 (ja) | 1997-11-04 | 2005-04-06 | キヤノン株式会社 | 光電変換装置、光電変換装置の駆動方法及びその光電変換装置を有するシステム |
| US6026317A (en) | 1998-02-06 | 2000-02-15 | Baylor College Of Medicine | Myocardial perfusion imaging during coronary vasodilation with selective adenosine A2 receptor agonists |
| WO1999053854A2 (en) | 1998-04-22 | 1999-10-28 | Cardiosynopsis, Inc. | Method and apparatus for treating an aneurysm |
| JP4318774B2 (ja) * | 1998-12-03 | 2009-08-26 | 株式会社日立メディコ | 磁気共鳴画像診断装置 |
| US6375668B1 (en) | 1999-06-02 | 2002-04-23 | Hanson S. Gifford | Devices and methods for treating vascular malformations |
| US6235024B1 (en) | 1999-06-21 | 2001-05-22 | Hosheng Tu | Catheters system having dual ablation capability |
| ATE470414T1 (de) | 1999-06-25 | 2010-06-15 | Vahid Saadat | Gerät zur gewebebehandlung |
| US6626855B1 (en) * | 1999-11-26 | 2003-09-30 | Therus Corpoation | Controlled high efficiency lesion formation using high intensity ultrasound |
| US7184827B1 (en) | 2000-01-24 | 2007-02-27 | Stuart D. Edwards | Shrinkage of dilatations in the body |
| US7373197B2 (en) | 2000-03-03 | 2008-05-13 | Intramedical Imaging, Llc | Methods and devices to expand applications of intraoperative radiation probes |
| US20030069525A1 (en) | 2000-03-08 | 2003-04-10 | Pharmasonics, Inc. | Methods, systems, and kits for plaque stabilization |
| US6597940B2 (en) | 2000-12-01 | 2003-07-22 | Neomed Technologies | Methods of detecting occlusion of the coronary artery system and imaging the heart |
| US20020103429A1 (en) | 2001-01-30 | 2002-08-01 | Decharms R. Christopher | Methods for physiological monitoring, training, exercise and regulation |
| US7105824B2 (en) | 2002-05-09 | 2006-09-12 | Neurologica, Corp. | High resolution photon emission computed tomographic imaging tool |
| US20030055360A1 (en) | 2001-09-05 | 2003-03-20 | Zeleznik Matthew A. | Minimally invasive sensing system for measuring rigidity of anatomical matter |
| US20030060813A1 (en) * | 2001-09-22 | 2003-03-27 | Loeb Marvin P. | Devices and methods for safely shrinking tissues surrounding a duct, hollow organ or body cavity |
| US6736809B2 (en) | 2001-09-26 | 2004-05-18 | Cryocath Technologies Inc. | Method and device for treatment of aneurysms |
| JP2005508171A (ja) | 2001-11-02 | 2005-03-31 | タノックス インコーポレーテッド | Ｂ細胞悪性病変の診断及び予防に用いるためのｂ細胞リンパ腫特異抗原 |
| US6928142B2 (en) | 2002-10-18 | 2005-08-09 | Koninklijke Philips Electronics N.V. | Non-invasive plaque detection using combined nuclear medicine and x-ray system |
| GB0228960D0 (en) | 2002-12-11 | 2003-01-15 | Mirada Solutions Ltd | Improvements in or relating to processing systems |
| WO2004086992A1 (en) * | 2003-03-28 | 2004-10-14 | C.R. Bard, Inc. | Junction of catheter tip and electrode |
| US7294125B2 (en) | 2003-08-22 | 2007-11-13 | Scimed Life Systems, Inc. | Methods of delivering energy to body portions to produce a therapeutic response |
| US20050049487A1 (en) | 2003-08-26 | 2005-03-03 | Johnson Bruce Fletcher | Compounds and kits for preparing imaging agents and methods of imaging |
| US20050240249A1 (en) | 2003-10-28 | 2005-10-27 | Hosheng Tu | Methods for treating mitral valve annulus with biodegradable compression element |
| US7318804B2 (en) * | 2003-12-09 | 2008-01-15 | The Regents Of The University Of Michigan | Methods and systems for measuring mechanical property of a vascular wall and method and system for determining health of a vascular structure |
| US8586932B2 (en) | 2004-11-09 | 2013-11-19 | Spectrum Dynamics Llc | System and method for radioactive emission measurement |
| US7734331B2 (en) | 2004-03-02 | 2010-06-08 | General Electric Company | Systems, methods and apparatus for preparation, delivery and monitoring of radioisotopes in positron emission tomography |
| EP1778957A4 (en) | 2004-06-01 | 2015-12-23 | Biosensors Int Group Ltd | OPTIMIZING THE MEASUREMENT OF RADIOACTIVE RADIATION ON SPECIAL BODY STRUCTURES |
| US8409099B2 (en) | 2004-08-26 | 2013-04-02 | Insightec Ltd. | Focused ultrasound system for surrounding a body tissue mass and treatment method |
| US7283654B2 (en) | 2004-08-26 | 2007-10-16 | Lumeniq, Inc. | Dynamic contrast visualization (DCV) |
| WO2008059489A2 (en) | 2006-11-13 | 2008-05-22 | Spectrum Dynamics Llc | Radioimaging applications of and novel formulations of teboroxime |
| US20060224090A1 (en) | 2005-03-29 | 2006-10-05 | Isaac Ostrovsky | Apparatus and method for stiffening tissue |
| US20070016039A1 (en) | 2005-06-21 | 2007-01-18 | Insightec-Image Guided Treatment Ltd. | Controlled, non-linear focused ultrasound treatment |
| US8837793B2 (en) | 2005-07-19 | 2014-09-16 | Biosensors International Group, Ltd. | Reconstruction stabilizer and active vision |
| US8644910B2 (en) | 2005-07-19 | 2014-02-04 | Biosensors International Group, Ltd. | Imaging protocols |
| US7601966B2 (en) | 2006-06-28 | 2009-10-13 | Spectrum Dynamics Llc | Imaging techniques for reducing blind spots |
| US10463886B2 (en) | 2007-02-22 | 2019-11-05 | Ramot At Tel-Aviv University Ltd. | Treating weakened vessel wall such as vulnerable plaque or aneurysms |
-
2008
- 2008-02-21 US US12/449,725 patent/US10463886B2/en active Active
- 2008-02-21 EP EP08710234.9A patent/EP2112911B1/en active Active
- 2008-02-21 WO PCT/IL2008/000234 patent/WO2008102363A2/en not_active Ceased
- 2008-02-21 EP EP13195255.8A patent/EP2730247B1/en active Active
- 2008-02-21 JP JP2009550369A patent/JP2010518942A/ja active Pending
- 2008-02-21 KR KR1020097018171A patent/KR20090121292A/ko not_active Ceased
Patent Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6475210B1 (en) * | 2000-02-11 | 2002-11-05 | Medventure Technology Corp | Light treatment of vulnerable atherosclerosis plaque |
| JP2004503277A (ja) * | 2000-03-08 | 2004-02-05 | ファーマソニックス，インコーポレイテッド | プラーク安定化のための方法、システムおよびキット |
| US20060058711A1 (en) * | 2000-07-13 | 2006-03-16 | Prorhythm, Inc. | Energy application with inflatable annular lens |
| WO2005030295A2 (en) * | 2003-09-24 | 2005-04-07 | Therus Corporation | Insertable ultrasound probes, systems, and methods for thermal therapy |
| WO2005076729A2 (en) * | 2004-02-12 | 2005-08-25 | Neurosonix Ltd. | Acoustic control of emboli in vivo |
| JP2007521908A (ja) * | 2004-02-12 | 2007-08-09 | ニューロソニック リミティド | 生体における塞栓音波制御 |
Also Published As
| Publication number | Publication date |
|---|---|
| WO2008102363A3 (en) | 2009-11-26 |
| EP2112911A2 (en) | 2009-11-04 |
| KR20090121292A (ko) | 2009-11-25 |
| EP2730247B1 (en) | 2017-04-26 |
| US20100081933A1 (en) | 2010-04-01 |
| HK1137918A1 (en) | 2010-08-13 |
| WO2008102363A2 (en) | 2008-08-28 |
| US10463886B2 (en) | 2019-11-05 |
| EP2730247A1 (en) | 2014-05-14 |
| EP2112911B1 (en) | 2014-10-01 |
| EP2112911A4 (en) | 2011-04-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US10463886B2 (en) | Treating weakened vessel wall such as vulnerable plaque or aneurysms | |
| JP6571719B2 (ja) | 経皮的超音波腎神経除去による高血圧症を治療するための方法及び装置 | |
| KR101640424B1 (ko) | 영상 유도 플라크 절제 | |
| US6451044B1 (en) | Method and apparatus for heating inflammed tissue | |
| US20130211396A1 (en) | Tissue treatment | |
| JP4686269B2 (ja) | 超音波治療装置 | |
| WO2014100226A1 (en) | Tissue ablation catheter and methods of ablating tissue | |
| EP2365843A1 (en) | Device for irradiating an internal body surface | |
| HK1137918B (en) | Apparatus for treating blood vessels by ultrasound | |
| Zeng et al. | Acoustic hemostasis of porcine superficial femoral artery: Simulation and in-vivo experimental studies | |
| HK1145072B (en) | A system for non-invasively and a controller |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20110215 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20110215 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20120925 |
|
| A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20120928 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20121225 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20130315 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20130612 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20130816 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20131113 |
|
| A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20131120 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20140110 |
|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20140530 |